Last reviewed · How we verify
Ringer's Lactate solution intravenously
Ringer's Lactate solution intravenously is a Small molecule drug developed by KAT General Hospital. It is currently FDA-approved. Also known as: R/L.
Ringer's Lactate solution is used intravenously to treat various conditions, including Acute Ischemic Stroke, Hemorrhagic Shock, Burns, Intoxication, and Neuromuscular Block, as per ClinicalTrials.gov. The exact mechanism of action of Ringer's Lactate solution is unknown, according to ChEMBL.
At a glance
| Generic name | Ringer's Lactate solution intravenously |
|---|---|
| Also known as | R/L |
| Sponsor | KAT General Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion (PHASE4)
- Effect of VExUS Ultrasound Protocol (Venous Excess Ultrasound) on Perioperative Fluid Management, on the Incidence of Postoperative Pulmonary Complications and Postoperative Acute Kidney Injury in Patients Undergoing Thoracic Surgery (NA)
- Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns (PHASE4)
- Investigation of Novel and Established Therapies in a Human Intravenous Lipopolysaccharide Model of Sepsis (PHASE1, PHASE2)
- Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery (EARLY_PHASE1)
- A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia (PHASE3)
- Effect of Intravenous Dextrose on PONV in Patients Undergoing Gynecological Laparoscopy (NA)
- Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ringer's Lactate solution intravenously CI brief — competitive landscape report
- Ringer's Lactate solution intravenously updates RSS · CI watch RSS
- KAT General Hospital portfolio CI
Frequently asked questions about Ringer's Lactate solution intravenously
What is Ringer's Lactate solution intravenously?
Who makes Ringer's Lactate solution intravenously?
Is Ringer's Lactate solution intravenously also known as anything else?
What development phase is Ringer's Lactate solution intravenously in?
Related
- Manufacturer: KAT General Hospital — full pipeline
- Also known as: R/L
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing